World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
40180
World Ranking
12026
National Ranking
1139

Overview

Emad A. Rakha is affiliated with the University of Nottingham in the United Kingdom and has a focused research profile in the fields of biochemistry, genetics, molecular biology, and medicine. Their work encompasses a substantial number of publications related to cancer research and oncology, emphasizing breast cancer and associated molecular mechanisms.

The scientist's main subfields of study include cancer research, oncology, molecular biology, pathology and forensic medicine, and radiology, nuclear medicine, and imaging. These fields highlight a multidisciplinary approach to cancer diagnosis, treatment, and biological understanding.

Research topics frequently addressed by Emad A. Rakha cover breast cancer treatment studies, breast lesions and carcinomas, cancer genomics and diagnostics, artificial intelligence applications in cancer detection, HER2/EGFR-related cancer research, cancer cell metastasis, and molecular pathways involved in cancer development.

Notable recent publications include:

  • IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis, 2020, Cancer Cell
  • Breast tumor microenvironment structures are associated with genomic features and clinical outcome, 2022, Nature Genetics
  • An update on the pathological classification of breast cancer, 2022, Histopathology
  • Determining breast cancer biomarker status and associated morphological features using deep learning, 2021, Communications Medicine
  • Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer, 2020, British Journal of Cancer

The scientist has collaborated extensively with several frequent co-authors, including Andrew R. Green, Michael S. Toss, Nigel P. Mongan, Ian O. Ellis, and Mansour Alsaleem, reflecting a consistent partnership in breast cancer and cancer biology research.

Emad A. Rakha's work has been published predominantly in several key scientific journals related to pathology and oncology. The most frequent publication venues include Histopathology, Breast Cancer Research and Treatment, Modern Pathology, Cancers, and Cancer Research. These venues indicate a focus on both clinical and molecular aspects of cancer science.

Best Publications

  • Prognostic markers in triple-negative breast cancer

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;Andrew H. S. Lee

  • Basal-Like Breast Cancer: A Critical Review

    Emad A. Rakha;Jorge S. Reis-Filho;Ian O. Ellis

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • Breast cancer prognostic classification in the molecular era: the role of histological grade

    Emad A. Rakha;Jorge S. Reis-Filho;Frederick Baehner;David J. Dabbs

  • A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

    Guido Rindi;David S. Klimstra;Behnoush Abedi-Ardekani;Sylvia L. Asa

  • Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Sunil Badve;David J. Dabbs;Stuart J. Schnitt;Frederick L. Baehner

  • Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

    Hamid Ali;E Provenzano;S-J Dawson;FM Blows

  • High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

    Dalia M. Abd El-Rehim;Graham Ball;Sarah E. Pinder;Emad Rakha

  • Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

    Emad A. Rakha;Maysa E. El-Sayed;Andrew H. S. Lee;Christopher W. Elston

  • Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.

    Emad A. Rakha;Somaia E. Elsheikh;Somaia E. Elsheikh;Muhammed A. Aleskandarany;Muhammed A. Aleskandarany;Hany O. Habashi;Hany O. Habashi

  • Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome

    Somaia E. Elsheikh;Andrew R. Green;Emad A. Rakha;Des G. Powe

  • Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

    Suzanne A. Eccles;Eric O. Aboagye;Simak Ali;Annie S. Anderson

  • Phyllodes tumours of the breast: a consensus review

    Benjamin Y. Tan;Geza Acs;Sophia K. Apple;Sunil Badve

  • Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

    E A Rakha;T C Putti;D M Abd El-Rehim;C Paish

  • Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor–Positive Phenotype

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;E. Claire Paish

  • Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

    Emad A Rakha;Richard W G Boyce;Dalia Abd El-Rehim;Thomas Kurien

  • Triple-negative/basal-like breast cancer: review

    Emad A. Rakha;Ian O. Ellis

  • Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

    Thomas C Putti;Dalia M Abd El-Rehim;Emad A Rakha;Claire E Paish

  • The prognostic significance of lymphovascular invasion in invasive breast carcinoma.

    Emad A. Rakha;Stewart Martin;Andrew H. S. Lee;David Morgan

  • Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

    Emad A. Rakha;Maysa E. El-Sayed;Desmond G. Powe;Andrew R. Green

Frequent Co-Authors

Ian O. Ellis
Ian O. Ellis University of Nottingham
Andrew R. Green
Andrew R. Green University of Nottingham
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Ritu Aneja
Ritu Aneja University of Alabama at Birmingham
Carlos Caldas
Carlos Caldas University of Cambridge
Sarah E Pinder
Sarah E Pinder King's College London
Andrew Evans
Andrew Evans University of Dundee
Puay Hoon Tan
Puay Hoon Tan Duke NUS Graduate Medical School
Stephen B. Fox
Stephen B. Fox Peter MacCallum Cancer Centre
Jonathan M. Garibaldi
Jonathan M. Garibaldi University of Nottingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine but looking for flexible ways to advance your career, pursuing an online healthcare degree may be the ideal solution. Healthcare is a broad field with diverse career opportunities beyond the traditional MD path.

For nurses keen on specialization, accelerated msn psychiatric np programs offer a quick route to becoming a Psychiatric Mental Health Nurse Practitioner. This can open doors to in-demand roles in mental health care.

Those interested in the administrative side of healthcare may consider a health administration degree online. These programs equip students with leadership and management skills vital for running medical organizations.

For advanced positions, affordable online mha programs present a practical pathway to a master’s degree, often at a reduced cost and with flexible schedules to suit working professionals.

Nurses aiming for the highest level of clinical practice should explore msn to dnp programs online. These Doctor of Nursing Practice pathways prepare graduates for leadership, research, and specialty care roles in today’s healthcare landscape.

Best Scientists Citing Emad A. Rakha

Trending Scientists

Recently Published Articles